Zobrazeno 11 - 20
of 47
pro vyhledávání: '"Heather Jane Au"'
Publikováno v:
The Journal of Men's Health & Gender. 4:44-51
Background Recent reports indicate that male breast cancer rates are increasing in North America. While there have been numerous large-scale studies examining women's experiences with breast cancer, to date there have been no North American studies e
Autor:
Anil A. Joy, Karen King, Sambasivarao Damaraju, Robert R. Bies, Michael Smylie, Carla M. Prado, Larissa J. Vos, Michael B. Sawyer, Vijaya L. Damaraju, Sheryl Koski, Andrew Scarfe, Mark Clemons, Katia Tonkin, Edith Pituskin, John R. Mackey, Diana Carandang, Carol E. Cass, Heather-Jane Au, John Hanson, Michelle Kuzma
Publikováno v:
Clinical breast cancer. 16(2)
Background Epirubicin is metabolized by uridine glucuronosyltransferase 2B7 (UGT2B7), an enzyme rich in single nucleotide polymorphisms (SNPs). We studied whether the −161 C > T germline SNP in UGT2B7 was related to epirubicin metabolism and whethe
Autor:
David Feeny, Melina W. Dharma-Wardene, D Dupere, John Hanson, Joanne D. Hewitt, Heather-Jane Au
Publikováno v:
Quality of Life Research. 13:1209-1216
The objective of this study is to evaluate whether patient-reported baseline health-related quality of life (HRQL) measured by the Functional Assessment of Cancer Therapy-General (FACT-G) instrument is predictive of survival for patients with advance
Autor:
Christopher M. Sellar, Robert G. Haennel, Neil Chua, Gordon J. Bell, Heather Jane Au, Kerry S. Courneya
Publikováno v:
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 39(6)
Exercise training improves health-related physical fitness and patient-reported outcomes in cancer survivors, but few interventions have targeted colorectal cancer (CRC) survivors. This investigation aimed to determine the feasibility and efficacy of
Publikováno v:
Journal of Urology. 159:1624-1629
We assessed the prognostic impact of genitourinary small cell carcinoma tumor and patient characteristics, and therapy.We retrospectively reviewed the records of 180 patients with genitourinary small cell carcinoma in which patient and tumor characte
Autor:
Jay Easaw, Derek J. Jonker, Ian Walters, Jenny Shannon, Jeremy Shapiro, Siobhan Ng, Lillian L. Siu, John Zalcberg, Christopher J. O'Callaghan, Andrew Strickland, Thierry Alcindor, Rami Kotb, Malcolm J. Moore, Heather Jane Au, Fabyolla El-Tahche, Sabe Sabesan, Mark Jeffery, Muhammad Salim, Jolie Ringash, Dongsheng Tu
Publikováno v:
Cancer. 120(2)
BACKGROUND The CO.20 trial randomized patients with K-RAS wild-type, chemotherapy-refractory, metastatic colorectal cancer to receive cetuximab (CET) plus brivanib alaninate (BRIV) or CET plus placebo (CET/placebo). METHODS Quality of life (QoL) was
Autor:
John A. Glaspy, Dennis J. Slamon, Wolfgang Eiermann, Maria J. Santana, Valerie Bee, John Crown, Tadeusz Pienkowski, Miguel Martin, S. Sehdev, Deepa Lalla, John R. Mackey, Tommy Fornander, Nicholas J. Robert, Dave P. Miller, Jean Marc Ferrero, Tamás Pintér, Mei Ching Liu, Arlene Chan, Heather Jane Au, M. Pawlicki
Publikováno v:
The oncologist. 18(7)
Background. This study aims to describe and compare health-related quality of life (HRQL) in patients with node-positive and high-risk node-negative HER2-positive early breast cancer receiving adjuvant docetaxel and trastuzumab-based or docetaxel-bas
Publikováno v:
Canadian family physician Medecin de famille canadien. 58(9)
To identify factors associated with delays to medical assessment and diagnosis for patients with colorectal cancer (CRC).Data were collected through a standardized questionnaire. Clinical records were also reviewed. When necessary, patients were cont
Autor:
Heather-Jane, Au, Jolie, Ringash, Michael, Brundage, Michael, Palmer, Harriet, Richardson, Ralph M, Meyer, Dongsheng, Tu
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 10(2)
Health-related quality-of-life (HRQoL) data are often included in Phase III clinical trials. We evaluate and classify the value added to Phase III trials by HRQoL outcomes, through a review of the National Cancer Institute of Canada Clinical Trials G
Publikováno v:
Expert opinion on biological therapy. 9(12)
Gastric cancer is a disease with different management approaches in different regions, especially between Western and Asian countries. Surgery is the mainstay of treatment for non-metastatic disease. Perioperative chemotherapy or adjuvant radio-chemo